ProMIS Neurosciences Inc (NASDAQ: PMN) on Monday, soared 11.35% from the previous trading day, before settling in for the closing price of $0.56. Within the past 52 weeks, PMN’s price has moved between $0.38 and $1.59.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -628.60%. With a float of $15.64 million, this company’s outstanding shares have now reached $32.69 million.
Considering the fact that the conglomerate employs 7 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
ProMIS Neurosciences Inc (PMN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of ProMIS Neurosciences Inc is 52.15%, while institutional ownership is 22.63%. The most recent insider transaction that took place on Feb 10 ’25, was worth 14,595. In this transaction Chief Scientific Officer of this company bought 15,000 shares at a rate of $0.97, taking the stock ownership to the 16,617 shares. Before that another transaction happened on Sep 24 ’24, when Company’s Director bought 70,000 for $1.30, making the entire transaction worth $91,028. This insider now owns 208,333 shares in total.
ProMIS Neurosciences Inc (PMN) Earnings and Forecasts
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.18 earnings per share (EPS) for the period topping the consensus outlook (set at -0.19) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -628.60% per share during the next fiscal year.
ProMIS Neurosciences Inc (NASDAQ: PMN) Trading Performance Indicators
ProMIS Neurosciences Inc (PMN) is currently performing well based on its current performance indicators. A quick ratio of 3.36 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.52 in one year’s time.
Technical Analysis of ProMIS Neurosciences Inc (PMN)
Compared to the last year’s volume of 2.91 million, its volume of 0.77 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 11.44%.
During the past 100 days, ProMIS Neurosciences Inc’s (PMN) raw stochastic average was set at 20.50%, which indicates a significant increase from 16.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1050 in the past 14 days, which was higher than the 0.0814 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5734, while its 200-day Moving Average is $0.7543. Nevertheless, the first resistance level for the watch stands at $0.6843 in the near term. At $0.7407, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8024. If the price goes on to break the first support level at $0.5662, it is likely to go to the next support level at $0.5045. Should the price break the second support level, the third support level stands at $0.4481.
ProMIS Neurosciences Inc (NASDAQ: PMN) Key Stats
Market capitalization of the company is 20.53 million based on 32,689K outstanding shares. Right now, sales total 0 K and income totals 2,780 K. The company made 0 K in profit during its latest quarter, and -7,350 K in sales during its previous quarter.
